Is it possible to achieve remission in severe asthma? Retrospective analysis of a four-year response in a real-life cohort treated with mepolizumab
<b>Conclusions:</b> By distinguishing these different degrees of response, clinicians can better understand the patient's condition and make more informed decisions about whether to continue with the current biologic therapy or consider switching to a different treatment.
Authors
- Santiago Quirce (ORCID: https://orcid.org/0000-0001-8086-0921)
- Javier Domínguez‐Ortega (ORCID: https://orcid.org/0000-0002-5397-2327)
- Daniel Laorden (ORCID: https://orcid.org/0000-0001-9054-5925)
- Jorge Correa-Borit (ORCID: https://orcid.org/0000-0002-6654-9704)
- Victoria Arnalich Montiel
Institutions
- Hospital Universitario La Paz (ES)
- Hospital La Paz Institute for Health Research (ES)
- Centro de Investigación Biomédica en Red (ES)
- Clinica de Pneumologie Iaşi (RO)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1080/02770903.2024.2441887
- Citations
- 4
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.31